eli lilly cfo on q2 earnings and coronavirus treatment
Published 4 years ago • 2.5K plays • Length 4:21Download video MP4
Download video MP3
Similar videos
-
4:17
eli lilly ceo on q2 earnings and core business performance
-
3:33
eli lilly reports results from covid-19 phase 2 antibody drug trial
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
4:39
eli lilly ceo on how covid-19 antibody drug helped drive q4 earnings
-
9:22
eli lilly ceo discusses its coronavirus antibody drug and the latest on its breast cancer treatment
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
4:29
get defensive and take a barbell approach to this market, says icapital's anastasia amoroso
-
3:26
tema etfs: supply is the real issue when it comes to weight loss drugs
-
4:27
jim cramer on eli lilly's covid-19 phase 2 trial results for antibody drug
-
1:44
eli lilly confirms it has paused one of its covid-19 antibody tests
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
2:47
eli lilly hopes to start testing coronavirus cure 'this summer': ceo
-
5:19
watch cnbc's interview with eli lilly's chief scientific officer on the new covid-19 antibody drug
-
4:03
lyft ceo david risher on q2 results
-
3:48
eli lilly’s chief scientific officer on covid antibody drug results
-
2:13
eli lilly ceo on covid antibody treatment's effectiveness against mutations
-
1:19
eli lilly begins phase 3 trial for covid-19 treatment
-
8:21
eli lilly ceo talks partnering with abcellera biologics to co-develop a coronavirus cure
-
4:40
eli lilly ceo on who advising against using remdesivir to treat covid-19
-
1:54
coronavirus: eli lilly launches first human trial of a new type of treatment
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
1:15
eli lilly starts late-stage trial for covid-19 antibody drug in nursing homes